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After chronic caffeine treatment (6 weeks, 0.2%
caffeine solution), the average body weights of rats
decreased by 6%, from 439 g in control to 412 g in
caffeine-treated group. There was a larger degree of
reduction (22%) in epididymal fat pad weight from 4.7 g
in control to 3.65 g in caffeine-treated group. In
addition, chronic caffeine treatment also induced a 10%
decrease in the mean cell diameter of adipocytes (86um
vs 77um). Nevertheless, there was no significant
change in the mean cell weight as well as the
triglyceride content of adipocctes from caffeine-
treated rats.
Adenosine appeared to be an important inhibitor of
lipolysis. Indeed, the addition of adenosine deaminase
can induce lipolysis in isolated adipocytes presumably
by lowering the endogenous adenosine level. Half-
maximal adenosine deaminase-induced lipolysis occurred
at a concentration of I U/ml and maximal response was
obtained at a concentration of 30 U/ml. There was no
significant difference in the adenosine deaminase
(30 U/ml) stimulated lipolysis between the control and
caffeine-treated rats. However, significant increase
in the anti-lipolytic potency of 2-chloroadenosine, a
metabolically stable adenosine analogue, was observed
after chronic caffeine treatment. The IC50 of 2-
chloroadenosine on adenosine deaminase (1 U/ml)
stimulated lipolysis decreased from 2.68 nM in control
rats to 1.09 nM in caffeine-treated rats.
Scatchard analysis of 3H-phenylisopropyladenosine
(PIA) binding in adipocyte membranes revealed an
increase in the maximal number (Bmax) of adenosine
receptors from 1.45 to 2.08 pmole/mg protein, while the
dissociation constant (KD) remained unchange after
chronic caffeine treatment. A consistent increase (10-
20%) in the brain cerebral cortex 3H-PIA binding sites
was also observed in caffeine-treated rats but they
were not significantly different from the controls.
Besides these adaptive changes in adenosine
receptors, there was also a significant change in the
l iPofYtic response stimulated by isoproterenol, a beta-
adrenergic receptor agonist, after chronic caffeine
treatment. The EC50 of isoproterenol increased from
77 nM in control rats to 110 nM in caffeine-treated
rats, accompanied by a 35% decrease in the maximal
lipolytic rate stimulated with 1 uM isoproterenol (6.5
vs 4.2 umole glycerol/g cells/30 min).
In agreement with these changes in the lipolytic
response to isoproterenol, chronic caffeine treatment
also diminished cAMP accumulation in intact adipocytes
stimulated by 100 uM isoproterenol, both in the
presence and absence of adenosine deaminase. On the
other hand, there was no significant difference in the
inhibitory potency of 2-chloroadenos ine on the
isoproterenol (100 uM) stimulated cAMP accumulation in
adipocytes from control and caffeine-treated rats.
Radioligand binding analysis showed that the
binding of 3H-d ihyroalprenolol (DHA) to beta-adrenerg is
receptors of adipocyte membranes demonstrated a
cooperat i v i ty. However, after 6 weeks 0.2% caffeine
treatment, no cooperat i v i ty was observed for 3H-DHA
binding to adipocyte membranes. Radioligand binding
analysis revealed a decrease in the number of be ta-
adrenerg is receptors on adipocyte membranes after
chronic caffeine treatment. However, there was no
significant difference in the 3H-DHA binding in brain
cerebral cortex membranes prepared from control and
caffeine-treated rats.
In summary, these data suggest that chronic
caffeine treatment sensitizes the adenosine Al
receptors, but desensitizes the beta-adrenergic system
in adipocytes. Since activation of Al adenosine and
beta-adrenergic receptors lead to an inhibition and
activation of lipolysis respectively, thus these
adaptive changes represent a homeostatic mechanism




4.L1? Ib taQl=2 n
Besides alcohol and nicotine, caffeine is probably
one of the most widely used psychoactive substance in
our society. It is present in large amounts in coffee,
tea, and cocoa as a natural product and as an additive
in many soft drinks. Chemically, caffeine is a
xanthine derivative. Pharmacologically, caffeine
produces bronchodilatory, cardiotonic and diuretic
effects. Biochemically, caffeine is a weak phospho-
diesterase inhibitor and a relatively more potent
adenosine receptor antagonist. Indeed, recent evidence
suggest that many biological effects of caffeine can
be attributed to its antagonism of adenosine receptors
(Fredholm, 1980 Snyder and Sklar, 1984).
Chronic exposure of receptors to its antagonist
usually leads to an increase in the receptor number.
This adaptive change may be responsible for the patho-
physiological syndrome sometimes observed upon
withdrawal of the antagonist as well as the development
of drug tolerance. For instance, after long-term
treatment of ischaemic heart disease with propranolol,
an increase in beta-•adrenergic receptor was found
(Aaron et al, 1980). Clinically, upon abrupt cessation
of propranolol treatment, an increase in anginal
symptoms, occurrence of myocardial infarction and
ventricular arrhythmias has been reported in some
5patients (Grahame-Smith, 1985). Powers (1925) reported
a syndrome associated with chronic heavy consumption of
caffeine, including vertigo, headache, nervousness,
visual disturbance and tachycardia. However, the effect
of chronic caffeine consumption on peripheral organs
has not yet been characterized. As adenosine is a well-
known anti-lipolytic agent in adipose tissues, the
present project was designed to study the effect of
chronic caffeine consumption on adenosine receptors in
adipocytes as well as the biological consequence of
such treatment.
1.2). The physiological roles of adenosine
Chemically, adenosine is a nucleoside, consisting
of a ribose and an adenine moiety. l inked together by a
N-glycosidic bond between the C-1 carbon atom of the
pentose and the N-9 nitrogen atom of the purine base
(Fig. 1.1). Biochemically, adenosine is a precursor of
ATP and GTP, and thus is an important substrate for
both energy metabolism and RNA/DNA synthesis. Recent
evidence suggest adenosine may also be a neuro-
transmitter in the central and peripheral nervous
system. Its possible involvement in the regulation of
many physiological functions is listed in Table 1.1.
In the nervous system, adenosine inhibits the
spontaneous neuronal firing of brain cerebral cortex
Fig. 1.1 Structure of some xanthine and adenosine





















































(Phi11is and Wu, 1983), and the release
norepinephrine and acetylcholine (Paton, 1979; Hayast
et al 1983). Furthermore, the sedative and anti
anxiety effects of neuroleptics, benzodiazepines ar
anti-de pressants seemed to correlate with thei
ability to potentiate central adenosine action k
inhibiting the adenosine uptake system (Phillis and Wt
1983)
In the cardio-vascu1ar system, adenosine is an
active vasodilator in the heart, brain, skeletal
muscle, intestine and lung, but it is a vasconstrictor
in the kidney and liver (Mentzer et al, 1975; Arch and
Newsholme, 1978; Berne et al, 1979). Adenosine also
produces negative chronotropic and negative inotropic
effects in the heart, and tracheal contraction in the
lung (Fredholm et al, 1979; Prasad et al, 1980).
Indeed, abnormality in adenosine regulation has been
suggested to be involved in the pathogenesis of
hypertension and asthma (Kamikawa et al, 1983). There
is also evidence in support of its role as a mediator
of hypoxic and reactive hyperemic coronary vasodilation
(Raberger, 1979).
At the cellular level, adenosine inhibits
aggregation of blood platelets (Haslam et si, 1979),
facilitates antigen-stimulate histamine release from
mast cells (Marquardt et al, 1978), inhibits
lymphocyte-mediated cytolysis (Wolberg et al, 1978),
9and stimulates steroidogenesis in adrenal and Leydig
cells (Condos et al, 1980). In adipocytes, adenosine
inhibits both lipolysis (Fredholm, 1978) and glucose
oxidation (Wong et al, 1985).
1.3) Metabolism of adenosine
1.3.1) Sources of adenosine
1.3.1.1) ATP pathway:
In the nervous system, ATP can be released either
from the pur inerg is nerves as a neurotransmitter, or
from the adrenergic nerves as a co-transmitter
(Burnstock, 1979 Su, 1983). The released ATP can be
degraded into ADP and AMP by adenosine triphosphatase
(ATPase). The AMP formed can be-further metabolized to
adenosine by the extracellular 5'-nucleotidase
(Fig. 1.2), which is primarily an ecto-enzyme.
Intracellularly, when the cellular AMP level is high as
a consequence of large energy demand, they can be
degraded into adenosine by the intracellular 5'-
nucleotidase. The adenosine thus formed can passed
through the cell membrane by facilitated diffusion into
the extracellular space and acts on the adenosine
receptors. Indeed, in view of the close relationship
between adenosine and the energy state of the cell,
Newby (1984) suggested that adenosine may function as a





















Fig. 1.2 Metabolic pathway of Adenosine
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local hormone to retaliate against an external stimulus
which would tend to cause excessive ATP breakdown.
1.3.1.2) Methylation pathway:
In addition to the afore-mentioned 'ATP pathway',
adenosine can also be generated from the 'methylation
pathway' (Fig. 1.2) (Arch and Newsholme, 1978 Daly,
1982). In cells, S-adenosyl-methionine generally
serves as the methyl group donor and itself being
converted to S-adenosylhomocysteine. Further
degradation of S-adenosylhomocysteine will generate
adenosine and homocysteine. It should be noted that
this reaction is readily reversible. Therefore,
depend on the cellular condition, the methylation
pathway can either serve to generate adenosine or to
maintain a low level of adenosine when homocysteine is
high.
1.3.2) Disposition of adenosine
Adenosine can be transported across cell membranes
via a facilitated diffusion process (Marangos et al,
1982). Once inside the cell, adenosine can be acted on
by two enzymes: adenosine deaminase and adenosine
kinase (Fig. 1.2). Adenosine deaminase converts
adenosine into inosine, which can be further
metabolized to hypoxanthine. If cellular nucleotides
are present in abundance, hypoxanthine will be
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converted to xanthine and then uric acid. Otherwise,
hypoxanthine will be recruited into the metabolic pool
through IMP by the salvage enzyme hypoxanthine-guanine
phosphoribosyl transferase.
Adenosine kinase converts adenosine to AMP, which
then enter the metabolic pool (Fig. 1 .2). The Km value
of adenosine kinase is about 50 fold lower than that of
adenosine deam inase. Moreover, the adenosine
concentration in tissues is larger than the Km value of
adenosine k inase in general. Therefore, most of the
adenosine will be rephosphorylated. However, in
situations when the adenosine level increases
drastically, adenosine deaminase will play an important
role in its removal. This is physiologically important,
because it prevents large amount of ATP being consumed
for the removal of adenosine by adenosine kinase (Arch
and Newsholme, 1978).
Currently, stable analogues of adenosine were
obtained by modifying the parent adenosine skeleton
(Fig. 1.1). Since both Al and A2 receptors can
tolerate only a very minor modification in the ribose
moiety of adenosine analogue for activity (see
section 1.4), most stable analogues of adenosine was
obtianed by modifying the purine ring of adenosine. For
instance, the stable analogue 2-chloroadenosine is
obtained by displacement of the hydrogen atom with a
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chloride atom at the C-2 carbon of the purine ring.
1.3.3) Cytotoxicity of adenosine
High cellular levels of adenosine can be cytotoxic
(Fox, 1982). When adenosine is accumulated in the
cell, owing to adenosine deaminase deficiency or other
reasons, it will be converted into deoxy-ATP. This
derivative can inhibit the ribonucleotide reductase, an
enzyme which converts ADP, GDP, UDP and CDP to the
corresponding deoxyribonucleotides for DNA and/or RNA
synthesis (Fig. 1.3). For an actively growing cell, a
decrease in DNA and/or RNA synthesis is expected to
hinder the growth and proliferation of the cell.
An accumulation of adenosine will also increase
the cellular level of S-adenosylhomocysteine, which in
turn can inhibit the cellular methylation reaction via
a feedback regulation (Fig. 1.4) (Fox, 1981). Like
phosphorylation and dephosphorylation reactions, the
methylation and demethylation reactions are
biologically important processes in the regulation of
enzyme activities in the cell. Methylation is also
important for the synthesis of many biomolecules
including phosphatidylcholine, norepinephrine,
creatine, and vitamin B12 (Alberts et al, 1983;
Lehninger, 1970). Therefore, an inhibition of this












Possible mechanism of feedback inhibition of
Fig. 1.3
ribonucleotide reductase during intra-
cellular accumulation of adenosine
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1.4) Classification of adenosine receetors and their
cellular mechanisms
Based on the relative potency of adenosine
analogues and their effects on adenylate cyclase and/or
cAMP accumulation, adenosine receptors are classified
into three different subtypes, namely Al or Ri. A2 or
Ra, and P (Londos and Wolff, 1977 Wolff et al, 1978
Van Calker et al, 1979 Londos et al, 1980 Daly,
1983). Their distinguishing features are summarized as
follows:
(A) Al or Ri adenosine receptors
a) Present on the outer surface of cell
membranes.
b) Can tolerate only very minor modification in
the ribose moiety of adenosine analogue for
activity.
c) Mediate an inhibitory effect on adenylate
cyclase and/or cAMP accumulation.
d) Possess a high affinity for adenosine
(submicromolar)
e) Have higher stereoselectivity (prefer L-PIA





g) Antagonized by xanthines.
(B) A2 or Ra adenosine receptors
a) Present on the outer surface of cell
membranes.
b) Can tolerate only very minor modification
in the ribose moiety of adenosine analogue
for activity.
c) Mediates a stimulatory effect on adenylate
cyclase and/or cAMP accumulation.
d) Possess a low affinity for adenosine (high
micromolar)
e) Have lower stereoselectivity (L-PIA only 3




g) Antagonized by xanthines.
(C) P adenosine receptors
a) Present inside the cell, with a possible
association with the catalytic unit of
adenylate cyclase.
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b) Can tolerate only minor modification in the
purine moiety for adenosine analogues for
activity.
c) Mediate an inhibitory effect on adenylate
cyclase and/or cAMP accumulation.






f) Not antagonized by xanthines.
There is a differential distribution of Al and A2
adenosine receptors in different tissue/organs. In
general, the A2 subtype seems to have a wider
distribution than the Al subtypes (Table 1.1). Besides
biological assays, radioligand binding studies using
3H-PIA, 3H-CHA and 3H --DPX have been used successfully
to identify and characterise the A l adenosine receptors
in neurons and adipocytes (Bruns et al, 1980 Trost and
Schwabe, 1981 Murphy and Snyder, 1982). On the other
hand, 3H-NECA can be used to label the A2 adenosine
receptors (Yeung and Green, 1984 Huttemann, 1984).
In addition to the well-known linkage of adenosine
receptors to adenylate cyclase, there are also evidence
indicating that adenosine receptor' activation can
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result in the regulation of Ca++ flux across cell
membranes (Stone, 198 1 S i 1 insky, 1981). Whether the
effect on Ca++ mobilization is secondary to its action
on adenylate cyclase or is mediated by a separate
mechanism remains to be investigated.
1_5) Triglyceride metaboloism
1 .5. 1) General aspect
Following feeding excess carbohydrates and fatty
acids will be transferred to adipose tissues, where
they will be stored in the form of triglycerides.
During fasting and exercise they can be released for
energy supply.
There are two types of adipose tissues, namely the
brown and white adipose tissues. The brown adipose
tissue, characterized by its high mitochondrial
content, is capable of oxidizing fatty acids at high
rate and generates heat. Mobilization of fatty acids
in the brown adipose tissue is controlled by the
sympathetic nervous system. Norepinephrine is released
from the nerve endings, which in turn activates the
lipase in adipocytes. Physiologically, brown adipose
tissues are important in thermogenesis in hibernating
animals and in neonates of many species including man
(Joel, 1965).
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Unlike the brown adipose tissue, the white adipose
tissue contains fewer mitochondria. Mobilization of
fatty acid is controlled by both the nervous system and
circulatory hormones. Physiologically, white adipose
tissue serves as an energy store. Upon complete
oxidation, fat gives more than twice the energy
available from protein or glycogen on equal weight
basis. Thus, when compared with glycogen and protein,
energy stored in white adipose tissue is much more
economical. Furthermore, white adipose tissue contains
much less water than other tissues, such as the liver
and muscle, thus making it a compact and rich
storehouse for energy.
1.5.2) Biosynthesis of triglyceride
Usually, adipose tissue of the land animal
contains 5-30% water, 2-3% protein, and 60-85% lipid.
Among the lipids, 90-99% are triglycerides, which
consist of three long-chain fatty acids linked through
ester bonds to the hydroxyl group of the glycerol.
Generally, one triglyceride molecule consists of two to
three different types of fatty acids of different chain
length and different degree of unsaturation. In rats,
similar to men, the ratio of saturated to unsaturated
fatty acid is about 3: 7. Sixteen and eighteen carbons
fatty acids are the major forms of saturated and
21
unsaturated fatty acids respectively (Jeanrenaud,
1965).
Adipose tissue has little or no glycerol k-inase,
thus could not reutilize the glycerol moiety released
from the triglyceride. Instead, alpha-
glycerophosphate, the active form of glycerol during
triglyceride synthesis, is derived from
dihydroxyacetone phosphate which is an intermediate in
the glucose oxidation pathway (Fig. 1.5). In contrast,
the free fatty acids (FFA) released from triglycerides
by hormone seneitive lipase (HSL) can be activated with
ATP and CoA by pyrophosphatase, and reused for
triglyceride synthesis (Fig. 1.5). Dietary fat is
another source of FFA. After digestion, FFA can be
absorbed in the intestine, and be incorporated into
triglycerides in the liver where the triglyceride can
combine with proteins to form chylomicrons. These
lipid-rich droplets are then circulated in the body
together with other blood components. When they reach
the adipose tissues, FFA is released from chylomicrons
by the action of a lipoprotein lipase. The FFA
released is then taken into adipocytes for triglyceride
synthesis. In addition, fatty acids can also be
synthesized de novo in adipocytes using carbohydrates
and acetyl CoA (Fig. 1.5) In human, de novo fatty acid
synthesis occurs mainly in the liver, where they are
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Fig. 1.5 Metabolism of triglyceride in rat epididymal
adipose tissue (Adopted from Denton and Pogson,
1976).
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tissues for triglyceride synthesis (Heisner and Carter,
1977).
Glucose oxidation, fatty acid and triglyceride
synthesis are all under the influence of various
hormones (Rodbell, 1965a). For instance, insulin and
oxytocin stimulate glucose oxidation as well as the
formation of fatty acid and triglyceride. Thyroid-
stimulating hormone (TSH), adrenocorticotropic hormone
(ACTH), and epinephrine stimulate glucose oxidation as
well as triglyceride synthesis, but decrease fatty acid
synthesis.
1.5.3) Mobilization of triglyceride from adipose tissue
Lipolysis refers to the process which mobilize
triglyceride from the adipose tissues. In adipocytes,
the breakdown of tr igl ycer ide is catalyzed by a
hormone-sensitive lipase (HSL). Currently, it is
widely believed that lipolytic hormones exert their
effects by increasing cAMP generation in adipocytes.
An elevated cellular cAMP level converts an inactive
cAMP-dependent protein kinase into an active form,
which in turn activates the HSL by a phosphorylation
reaction (Fig. 1.6) (Meisner and Carter, 1977
Steinberg, 1976). Evidence in support of the 'cAMP
hypothesis' include the following:
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Fig. 1.6 Possible mechanism of activation of hormone
sensitive lipase (Adopted from Steinberg, 1976)
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are able to increase cAMP levels in adipocytes
(Butcher et a], 1968)
b) Forskolin which activates the catalytic unit of
adenylate cyclase can induce lipolysis in
adipocytes (Litosch et al, 1982)
c) Inhibition of phosphodiesterase with 1-methyl-3-
isobutylxanthine (IBMX) and R0-20-1724, which
leads to an accumulation of cAMP, also increases
the rate of lipolysis (Shechter, 1984).
d) Salicylate and acetylsalicylic acid which inhibit
the binding between protein kinase and cAMP also
inhibit lipolysis (Schonhofer et al, 1973)
e) Hormone sensitive lipase can be activated by
exogenous protein kinase prepared from bovine
skeletal muscle. However, HSL prepared from
adipose tissues that has been pre-incubated with
NE gave a lower degree of activation by the
protein k inase. The results suggested that most
HSL has been activated by the NE-stimulated cAMP
accumulation, thus a lower degree of activation
of HSL by exogenous protein kinase was obtained
(Khoo and Steinberg, 1974).
In addition to the hormone sensitive lipase,
diglyceride and monoglyceride hydrolase activities are
also present in adipose tissues (Steinberg, 1976).
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Although the degree of activation by cAMP of these
glyceride hydrolase is much lower than that of HSL,
their enzyme activity against di-, and monoglycerides
is much higher than that of HSL. Consequently, it is
likely that the hydrolysis of the first ester bond of
triglyceride by HSL may be the rate-limiting step in
FFA mobilization.
1.6) Regulation of lipolysis
1.6.1) Intrinsic factors
1.6.1.1) Age
The rate of lipolysis stimulated by epinephrine
and ACTH is age-dependent, being higher in younger
rats. On the other hand, there i.s no age difference in
the theophyl l ine-stimulated l ipolys is. (Miller and
Allen, 1973). Dax and co-worker (1981) found that
there was no difference in the beta-adrenergic receptor
number and the response of cAMP accumulation to
epinephrine, they therefore concluded that the age-
dependent decrease in lipolysis to epinephrine and ACTH
may be due to an alternation of the lipolytic pathway
beyond the level of receptors occupancy and its
coupling to adenylate cyclase.
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1.6.1.2) Cell size
When the rate of lipolysis is expressed in term of
umole FFA/105 cells it was found that the rate of
lipolysis correlated linearly and positively with the
cell diameter (Zinder and Shapiro, 1971 Reardon et al,
1973 Vernon and Finley, 1985). However, when the rate
of lipolysis is expressed in
umole FFA/umole triglyceride, there is a negative
linear correlation between the cell diameter and
lipolytic rates (Reardon et al, 1973).
1.6.2) Extrinsic factors
1.6.2.1) Free fatty acid
FFA produced in lipolysis can be removed either by
re-esterification with alpha-glycerophosphate, or by
diffusion out of the adipocyte. Since FFA is
hydrophobic, it usually binds to a carrier such as
albumin for transport. Rodbell (1965b) showed that, in
the absence of glucose, there was a decrease in the
efflux of FFA and glycerol when the molar ratio of FFA-
to-albumin exceeds 3. The efflux of FFA was completely
inhibited when the ratio exceeds 6. If glucose was
added to the medium to increase the re-ester i f icat ion
of FFA, an enhancement of lipolysis was observed (Bally
et al, 1965). These experiments suggest FFA may act as
a feedback inhibitor to regulate lipolysis.
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1.6.2.2) Hydrogen ion (H+)
Hydrogen ion and FFA are released
stoichiometrically during lipolysis, therefore, an
accumulation of FFA in the medium is accompanied by an
acidification of the extracellular space. Meisner
(1977) demonstrated that there was about 50% decrease
in FFA efflux when adipocytes were suspended in a
buffer at a pH of 6.8, instead of 7.4. Poyart and co-
worker (1967) showed that an acidic environment would
favor the accumulation of FFA in adipocytes which will
in turn inhibit lipolysis (see section 1.6.1.1)
1.6.2.3) Lipolytic hormone
Norepinephrine, epinephrine, TSH, ACTH and
glucagon are all able to mobilize fatty acids from
adipocytes in in vitro experiments. All these
lipolytic hormones stimulate cAMP accumulation in
adipocytes and only ACTH requires Ca++ ion for its
lipolytic activity (Allen et al, 1977). Although the
level of circulating catecholamine is low, a
physiological role of neuronal catecholamine in
lipolysis was demonstrated by stimulating the
sympathetic nerve in vitro (Correll, 1963).
Growth hormone, thyroid hormone, and
cort icoster i ods do not mobilize fatty acid directly,
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but their presence are important for hormone stimulated
lipolysis. For instance, hypophysectomized and
adrenalectomized animals have a lower basal rate of
lipolysis as well as diminished response to lipolytic
stimuli (Shafrir et al, 1960). Adipose tissues from
hypothyroid animals also show a markedly lower response
to lipolytic stimuli (Deykin and Vaughan, 1963).
1.6.2.4) Anti-lipolytic agents
Insulin, adenosine, and prostaglandins are all
able to inhibit the hormone stimulated lipolysis. All
three hormones inhibit the hormone stimulated cAMP
accumulation in adipocytes (Meisner and Carter, 1977
Fredholm, 1978). However, the effects of prostaglandin
synthesis inhibitors and antagonists on lipolysis and
cAMP accumulation are controversial. A role of
prostaglandins as a feedback regulator of lipolysis is
still an open question (Fredholm, 1978). Adenosine can
potentiate the effect of insulin on both lipolysis and
glucose oxidation, even though different mechanisms are
involved in these two processes (Schwabe, 1974).
CHAPTER 2
M E T H D D D L D G Y
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2.12 Eal
Both male and female Sprague -Dawley rats were bred
and grew in the animal house of Chinese University of
Hong Kong. They were kept in rooms with a light-dark
cycle of 12 h time interval. Drinking solution and
pellet diet (Formerly Laboratory Chow 5001C, Dean's
Animal Feeds) were given ad libitum. The body weight
of rats increase rapidly between the sixth and the
twelfth weeks of age (Fig. 2.1).
2.22 Cbrooic Caffeine Treatment
For each treatment, 8 male rats (200-250 g) from
two age-matched (about 7 weeks) litters were equally
divided into two groups. The control group received
water while the caffeine group was given a solution
tap
of caffeine (Merck) for 6 weeks or for as long as
indicated. The amount of water and caffeine solutions
When
consumed were recorded on alternate days.
with the control group, it was found that the
comparing
daily fluid consumption of the experimental group given
0.2% caffeine. solution was lowered by about 20%. In
contrast, there was a 35% increase in daily fluid
intake in the group given 0.05% caffeine solution. No
significant difference, however, was observed between
and those received 0.1% caffeine solution
the controls
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Fig. 2.1: Growth curves C in terms of body weight) of male(•)
and female (0 rats after birth. Data presented are









0.10% 10736.3+ 3.933.4+ 5.5
28735.9+ 2.5*46.0+ 2.60.20%
Caffeine was adminstrated to rats by replacing the drinking water with
caffeine solutions. Value presented are the mean+ S.D. of 21
determination from one treatment.* P0.05 when compare with control
by using Students' t-test.
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consumption (about 10%) towards the end of the 6-weeks
treatment period in both control and caffeine treated
groups (Fig. 2.2).
2.3) -I-s-oproterenol Treatment
D,L-Isoproterenol (0.2 mg/ml, Sigma) was
administered to male rats (300-350 g) by subcutaneous
injection at a dosage of 0.2 mg/kg body weight every
12 h for 6 days. Control male rats were injected with
the same volume of saline vehicle.
2.4) Adl2ggyte Counting
An improved Neubauer haemocytometer was used for
fat cell counting. When compared with blood cells,
adipocytes have larger cell diameters. In order to
obtain higher cell counts, the whole ruled area,
instead of just the central ruled area was used for
adipocyte counting. Since the whole ruled area is
3 mm x 3 mm with a depth of 0.1 mm, the total volume of
the ruled area is 9x10-4 cm3. Thus the cell
concentration:
Cell number in the ruled area
cells/ml
9x104
Fig. 2.2:Consumption of tap water• and 0.2% caffeine
solution 0 in the control and caffeine-treated
group respectively, over the 6 weeks experimental
period. Data showed are the mean of 2-4 separated
treatments, with deviation less than 10% of the mean.
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2.5) Measurement of Adipocyte Weiqh
Under vacuum filtration, aliquots of fat cells
were collected on Whatman GF/B glass fibers in
duplicate. They were dried in an incubator set at 800
for at least 24 h. As the average weight-of a GF/B
filter is 70.1 mg, this was substracted from the weight
of dried filters with adipocytes to give the dry weight
of adipocytes.
2.26) Determination of Adipocyte Size
As described previously (Ashwell et al, 1976),
photomicrographs of isolated adipocytes were taken at a
proper magnification (100x) together with a ruler. The
diameter of isolated adipocytes were measured on the
photographs. To avoid bias in sampling, three
photomicrographs were prepared for each adipocytes
sample, and the number of adipocytes distributed around
the central horizontal line in photographs was counted.
Assuming the adipocytes are spherical and their cell
volumes can be calculated according to equation 2.1 as
described by Goldrick (1967):
(2.1)
where X= mean cell diameter.
2= variance of the cell diameters.
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2 .7) Triqlyceride Determination
A hydroxamic acid reaction was initially developed
by Goddu et al (1955) for the spectrophotometric
determination of esters and anhydrides. This reaction
was adopted by Rapport and Alonzo (1955) for
triglyceride determination. In principle, triglyceride
is hydroxylaminolyzed and the fatty acids formed can
react with hydroxylamine to form hydroxamic acid
(equation 2.2.). The resulting hydroxamic acid can
combine with ferric acid to give a characteristic red
to purple chelated complex (equation 2.3).
(2.2)
(2.3)
Maximal colour yield was obtained when the final
ferric ion concentration was greater than 2 mM and that
of hydrogen ion concentration was less than 0.6 M
(Goddu et al, 1955). It should be noted that this
assay is not specific for triglycerides. A positive
result can be obtained with any fatty acid ester.
Furthermore, high concentrations of carbonyl compounds,
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transition elements, ions or any compound which can
complex with ferric ion may affect the intensity of the
colour. The rate of formation of hydroxamic acid is
affected by both temperature and the type of ester
used, so colour yield is also temperature sensitive.
2.7.1) Stock reagents
a) Ethanol hydroxylamine hydrochloride:.
Hydroxylamine hydrochloride (0.6 g) was
dissolved in I ml water and then mixed with
19.ml absolute ethanol.
b) Ethanolic sodium hydroxide:
Sodium hydroxide (0.6 g) was dissolved in 1 ml
water and then mixed with 19 ml absolute
ethanol.
c) Ferric pe rch l orate:
Iron wire (0.8 g) in 10 ml of 70% perchloric
acid was dissolved by heating on a hot plate.
Upon cooling, the solid residue was
redissolved in 10 ml water and diluted with
absolute ethanol to 100 ml.
2.7.2) Working reagents
a) Alkaline hydroxylamine:
Equal volumes of ethanolic hydroxylamine
hydrochloride and ethanolic sodium hydroxide
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were mixed. After a few minutes, the sodium
chloride precipitate was removed by
filtration. The reagent was stable for about
5 h.
b) Ethanolic acid ferric prechlorate:
Ferric perchlorate (4 ml) was mixed with
1.2 ml perchloride acid and then diluted with
absolute ethanol to 100 ml.
2.7.3) Preparation of triglyceride standards
a) Glycerol triacetate was used as standard. It was
dissolved in chloroform to give a stock
concentration of 5 mM.
b) The stock solution was diluted with chloroform to
give the following concentrations: 1, 2, 3, 4,
and 5 mM.
2.7.4) Extraction of triglyceride
a) Equal volumes of adipocyte suspension and
chloroform were mixed vigorously. After
centrifugation, the top aqueous layer was aspirated
off.
b) The chloroform extracts were diluted 20 to 40 fold
and their tirglyceride contents were determined.
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2.7.5) Assay protocol
a) Ether (3 ml) was added to tubes containing 100 ul
samples or standard.
b) Alkaline hydroxylamine (100 ul) was added and
mixed.
c) The tubes were incubated in a water bath (65-700)
in a fume-hood to facilitate the formation of
hydroxamic acid and to evaporated the ether.
d) Residual ethanol was removed by suction under
reduced pressure.
e) Ethanolic acid ferric perchlorate (2 ml) was added
and the mixture kept to stand for 30 min.
f) Absorbance was read at 530 nm.
A typical standard curve for triglyceride determination



















CONCENTRATION OF GLYCEROL TRIACETATE, m
Fig. 2.3: : A typical calibration curve for triglyceride
determination. Values presented are the mean of
duplicate determinations from one typical experiment.
The straight line was determined by linear regression
analysis. Each experiment has an individual
calibration curve performed in parallel.
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2.8) Lipolysis Assay
In the presence of a lipolytic hormone, a hormone
sensitive lipase will be activated and catalyzed the




H-C-O-C-R CHOH 3 RCOOH
CH2OH
H2C-O-C-R
Although both glycerol and free fatty acid.(FAA) are
released from the adipocytes, FFA will be-
reincorporated into tr igl ycer ide after reuptake and
activation to acyl CoA derivative. On the other hand,
because of the extremely low level of glycerol kinase,
the glycerol cannot be incorporated significantly after
its release (Steinberge and Khoo, 1977). Therefore, in
the present study, lipolysis was determined by
measuring the amount of glycerol released.
2.8.1) Buffer
2.8.1..1) Krebs-Ringer Bicarbonate Buffer (KRB)
KRB was prepared freshly on the day of experiment.
The buffer had the following composition (mM): CaC12
(2.5), MgSO4 (2.4), KH2PO4 (1.2), KC1 (4.8), NaCl
(119), NaHCO3 (32.5). It was gassed with 95% 02-
5% CO2 for 30 min to give a pH of 7.4 and then kept in
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a 37° water bath.
2.8.1.2) Bovine serum albumin supplemented Krebs-Ringer
bicarbonate buffer (BSA- KRB)
KRB after prepared according to section 2.8.1.1
was supplemented with 1-4% bovine serum albumin
(Fraction 5, 96-98% purity, Sigma). After the BSA was
completely dissolved, pH of BSA-KRB was adjusted with
1 N NaOH or 1 N HCl to 7.4, and then kept in a 37°
water bath.
2.8.2) Preparation of adipocytes
Adipocytes were prepared according to the method
described by Rodbell (1964) with some modifications:
a) Rats were killed by cervical dislocation.
Ep id idymal fat pads were removed i mmed iatedl y and
rinsed with 0.9% NaCl solution.
b) After dissecting free of blood vessels, the fat
pads were weighed and minced.
c) The minced tissues were suspended in 4% BSA-KRB
(1 ml/g tissue) containing collagenase (1 mg/ml,
from Clostridium histolyticum, Sigma) in 50 ml or
20 ml plastic tubes. They were incubated at 370 in
a water bath with continuous shaking (80-
100 cycles/min) for 60-90 min.
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d) Collagenase treatment was terminated by adding 2
volumes of KRB at 37°. Adipocytes were collected by
filtering the mixture through a layer of
cheesecloth.
e) The filtrate was centrifuged with a clinical table-
top centrifuge (ICE) at low speed (about 250xg) for
about 30s at room temperature.
f) After centrifugation, ad i pocyte s floated to the
surface which facilitated the removal of buffer
using .a Pasteur pipette. Adipocytes were
resuspended in 10 ml of 1% BSA-KRB and swirlled
gently to disperse the cells.
q) Step (e) and (f) were repeated 2-3 times.
h) For lipolysis assay, adipocytes were resuspended in
4% BSA-KRB (3 ml/ml isolated adipocytes).
i) To give a final volume of 500u1, 350u1-450u1 of the
adipocyte suspension were dispensed into 1.5 ml
plastic microcentrifuge tubes (Eppendorf) with
various test drug(s) at 370 in a water bath with
continuous shaking (about 35 cycles/min) and
gassing (95% 02-5% C02). Assays were performed in
duplicate.
After an appropriate interval (30-90 min),
3)
incubation was terminated by adding 0.5 ml of 10%
trichloroacetic acid. The reaction mixture was
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centrifuged at about 10000xg for 5 min at room
temperature.
k) Three layers were obtained after centrifugation.
The top layer was fat and the bottom layer was
denatured protein. Two hundred microlitres of the
middle aqueous layer were used for glycerol
determination within 24 h.
2.8.3) Glycerol determination
The method for glycerol determination was adopted
from Lambert and Neish (1950) with some modifications.
In Principle, 1 mole of glycerol is oxidized by
periodate to form 1 mole of formic acid and 2 moles
of formaldehyde. After neutralization of the excess
periodate with metabisulphite, the formaldehyde formed
can be determined colorimetrically by reacting with
chromotropic acid (MacFadyner, 1945).
Compounds that have two hydroxy groups or a
hydroxyl and an amino group, or two carbonyl groups or
a hydroxyl and a carbonyl group in the adjacent carbon
atom can be oxidized by periodate to form formaldehyde.
Oxidation has also been reported to occur with cystine,
methionine and tryptophan which contain nitrogen but
al ha-amino-alcohol structure (Jackson,
possess no p
samples for glycerol determination
1944). Therefore,
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should be free of sugar, protein and other compounds
with the afore-mentioned chemical structures.
2.8.3.1) Reagents
a) 12.5 N H2SO4
b) I N H2SO4
c) 50 mM sodium periodate
d) 10% sodium metabisulphite
2.8.3.2) Prparation of chromotropic reagent
Chromotropic reagent (500 ml) was prepared freshly
by dissolving one gram of 4,5-dihydroxynaphthalene-2,7-
disulfonic'acid (Sigma) in 100 ml water, and then 400
ml 12.5 N sulfuric acid were added and mixed
thoroughly.
2.8.3.3) Preparation of glycerol standard
Stock glycerol solution (2 umole/100 ul) was
diluted in water to give a working solution of
40 nmole/100 ul. The working solution was serially
diluted to give the following concentrations: 40, 20,
10, 5, and 2.5 nmole/100 ul.
2.8.3.4) Assay protocol
a) Fifty microlitres of 1 N sulfuric acid were added
to tubes containing 200 ul samples or standards
b) Fifty microlitres of 50 mM sodium periodate were
added, mixed and left to stand for. 5 min.
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c) Fifty microlitres of 10% sodium metabisulphite
were added, mixed and left to stand for 5 min.
d) Two millitres of chromotropic reagent were added.
e) Tubes were covered with tin foil and boiled for
30 min.
f) Water (0.5 ml) was added and the reaction mixture
allowed to cool down to room temperature.
g) Absorbance was read at 570 nm.
A typical standard curve for glycerol determination is
shown in Fig. 2.4.
2.8.4) Data analysis by the Hill plot






n= theoretical number of drug-
































CONCENTRATION OF GLYCEROL, fiM
Fig. 2.4: A typical calibration curve for glycerol
determination. Values presented are the mean of
duplicate determinations from one typical
experiment. The straight line was determined by linear
regression analysis. Each experiment was accompanied







= f (R+ RLn)
= fR+ (E-Eo)
(2.7)Emax-E= fRthus





Therefore, when a dose response curve is transformed to
a Hill plot according to equation 2.8 by plotting
log((E-Eo)/(Emax-E)) vs log (L), a straight line can be
obtained. At half-maximal response (E-Eo)/(Emax-E)= 1,
and log 1= 0. Therefore, the concentration of drug







n log (L) log KD
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be obtained from the Hill plot by finding corresponding
value of log (L) at log ((E-Eo)/(Emax-E))= 0.
2.9)OAMP Aooumulation Assay
2.9.1) Stimulation of cAMP accumulation
a) Isolated adipocytes were prepared as described in
section 2.8.2 and resuspended in equal volumes
(v/v) of 4% BSA-KRB.
b) To give a final volume of 1 ml, 700-900 ul of
adipocyte suspension were dispensed into 1.5 ml
plastic microcentrifuge tube and incubated with
various test drug(s) in a water bath at 370.
Reaction was started by adding isoproterenol.
c) After 5 min or as indicated, incubation was
terminated by heating in a boiling water bath for
5 min.
d) Upon cooling, the reaction mixture was centrifuged
at about 10000xg for 20 min at room temperature.
e) Three layers were obtained after centrifugation and
50 ul of the middle aqueous layer were 'taken out
for cAMP determination performed within 3 h.
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2.9.2) cAMP determination
In principle, the assay is based on competition
for binding to an adrenal cAMP binding protein between
unlabelled cAMP and a fixed amount of 3H-cAMP. With
increasing levels of cAMP in the sample, the amount of
3H-cAMP bound to the cAMP-binding protein decreases
proportionally. After removal of unbound 3H-cAMP by
adsorption onto charcoal, the protein-bound
radioactivity cab be determined. The amount of cAMP in
sample can be calculated by comparing with a standard
curve performed in parallel.
Although cGMP and ATP are the two naturally
occurring nucleotides most likely to interfere with the
binding of cAMP to its binding protein (Albano et al,
1974 Brown et al, 1972), it was found that ATP did
not interfere at concentrations up to 5 mM (Tovey
et al, 1974). Moreover, 200 times as much cGMP as cAMP
is required to give an equivalent reducton in the
binding of tritated cAMP (Tovey et al, 1974). In
mammalian tissues, the concentration of cAMP is
generally about 100 times higher than that of cGMP
(Steiner et al, 1972), therefore the normal tissue cGMP
is unlikely to affect the present cAMP assay. Divalent
ions such as Mgtt and Catt have been reported to reduce
the binding of 3H-cAMP to the cAMP-binding protein
(Tovey et al, 1974). The intereference of these
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divalent ions was prevented by adding 4 mM EDTA to the
assay buffer in the present study.
2.9.2.1) Preparation of cAMP binding protein
Binding protein was prepared according to the
method of Brown et al (1972). Briefly,
a) Bovine adrenal glands (20 pairs) were freshly
collected from a slaughter house and kept on ice.
b) After removal of fats, the adrenal cortex was
separated from the medulla.
c) The medulla was homogenized with 1.5 vol (v/w) of
Medium A (0.25 M sucrose, 25 mM KC1, 5 mM MgC12 and
50 mM Tris-HC1, pH=7.4 at room temperature).
d) The homogenate was centrifuged at 10000xg for
5 min, the pellet was discarded.
e) The supernatant was centrifuged again at 10000xg
for 15 min, the pellet was discarded.
f) The supernatant was divided into 500 ul portions
and stored at -200.
g) For cAMP measurement, the binding protein was
thawed and diluted 20 fold with the assay buffer
to give a total binding of around 6000'cpm at a
final 3H-cAMP concentration of 4.5 nM.
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2.9.2.2) Preparation of charcoal solution
Activated charcoal (neutral, Sigma) was stirred in
the assay buffer (50 mM Tris-HC1, 4 mM Na2EDTA, pH 7.4
at room temperature) containing 2% BSA to give a
charcoal concentration of 75 mg/ml.
2.9.2.3) Preparation of working 3H-cAMP solution
3H-cAMP (specific activity: 23.6 uCi/mmole,
Amersham) was diluted with assay buffer to give an
18 nM solution. This solution was freshly prepared
before each experiment.
2.9.2.4) Preparation of CAMP standard
Stock cAMP solution (16 pmole/50 ul, Amersham) was
diluted serially with assay buffer to give the
following concentrations: 1, 2, 4, and 8 pmole/50 ul.
2.9.2.5) Assay protocol
a) The following aliquots (ul) in duplicate was added








b) Fifty microlitres of working 3H-cAMP solution was
added to each tube.
c) One hundred microlitres of the cAMP binding protein
solution was added to each tube except the blank.
d) After mixing, the tubes were kept at 40 for 2 h.
e) One hundred microlitres of a well-stirred charcoal
suspension was added to each tube, mixed, and then
centrifuged within 2 min, at 10000xg at 40 for 10
min.
f) Without disturbing the sediment, 200 ul of the
supernatant were taken out for radioactivity
measurement by liquid scintillatin counting in a
home-made scintillation fluid (0.4 g POPOP, 4 g
PPO, in 1 litre mixture of 666 ml toluene and
333 ml Triton X-100).
2.9.2.6) Data calculation
a) Specific binding of 3H-cAMP was calculated by
subtracting the value of blank.
b) The specific binding in the absence of unlabelled
cAMP (standard zero) was designated as Co, while
the specific binding. i n the presence of unlabelled
cAMP from standard or sample was designated as Cx.
c) The ratio of Co/Cx was calculated for each tube.
54
d) A linear calibration curve was obtained by plotting
Co/Cx against pmole of standard cAMP.
e) The amount of cAMP in the sample was read off from
the standard curve using their Co/Cx values.
A typical calcibration curve for cAMP determination is
shown in Fig. 2.5.
2_10) Radioligand Binding Analysis
A biological response is elicited by the occupancy
of receptors with its specific agonist. In 'test tube'
experiments, the association of receptors and its
specific agonists can be demonstrated by using
radioactive isotope labelled agonist as the tracer.
The binding of a radiolabelled ligand to its
receptor is saturable and reversible. Kinetically, the
binding reaction obeys the Law of Mass Action and will
attend an equilibrium state after an appropriate
period of incubation. After reaching equilibrium, the
unbound radiolabelled ligand can be separated from the
bound radiolabelled ligand by rapidly passing the
reaction mixture through a glass microfibre filter
which retain the membranes as well as the bound





Fig. 2.5 : A typical calibration curve for cAMP determination.
Values presented are the mean of duplicated
determinations from one typical experiment. The
straight line was determined by linear regression
analysis. Each experiment was accompanied by an
individual calibration curve. Co and Cx are the
binding of 3H-cAMP in the absence and presence of
unlabelled cAMP respectively.
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2.10.1) Preparation of cerebral cortex membranes
Brain cerebral cortex was homogenized in 10 vol
(v/w) of ice-cold buffer B (50 mM Tris-HC1, pH 7.4 at
25°) using a Brinkmann polytron PT-10 (setting 6, 10-
15s). The homogenate was centrifuged at 45000xg for 10
min and the pellet was resuspended in 20 vol of buffer
B. This washing procedure was.repeated twice. The crude
membrane preparation was stored as a pellet at- 200.
2.10.2) Preparation of adipocyte membranes
2.10.2.1) Lysing medium
As described previously (Rodbell, 1972), the
lysing medium was prepared freshly on the day of
experiment. The lysing medium had the following
composition (mM): MgC12 (2.5), CaC12 (0.1) KHCO3 (1.0)
and Tris (2.0). The pH of the medium was adjusted to
7.4 with 1 M HCl at room temperature.
2.10.2.2) Protocol
a) Adipocytes were isolated as described in
secton 2.8.2 and washed twice with 1% BSA-KRB.
b) Ice-cold lysing medium (10 ml) was added to the
tube containing washed adipocytes, and the cells
were dispersed by gentle swirlling.
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c) The suspension was centrifuged at about 250xg in a
table-top centrifuge for 30s and the infranatant
fluid was aspirated off.
d) Another 10 ml of ice-cold l ys ing medium were added.
Adipocytes were broken by inverting the tubes 20
times, using vigorous shaking motion at each
downward stroke.
e) The tubes were centrifuge at about 1600xg for about
60s.
f) The cloudy infranatant was transfered to a 50 ml
centrifuge tube with a Pasteur pipette.
g) Steps (d), (e) and (f) were repeated, and the
infranatants were combined.
h) The combined infranatant was .centrifuged at 45000xg
for 15 min at 40.
i) The supernatant was discard. The pellet was
homogenized in 10 ml ice-cold buffer B with a
Brinkmann polytron PT-10 (setting 6, 10-15s)
j) The homogenate was centrifuged at 45000xg for
15 min and the pellet was washed two more times in
10 ml ice-cold buffer B.
For radioligand receptor binding analysis, the
k)
pellet was resuspended in ice-cold buffer B to give
a protein concentration of about 0..8 mg/ml.
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2.10.3) Adenosine receptor binding
Similar to published methods (Lohse et al, 1984
Trost and Schwabe, 1981), binding experiment was
initiated by adding 140 ul of adipocyte or cerebral
cortex membranes in duplicate to 0.5-20 nM of
3H-phenylisopropyladenosine (3H-PIA, Amersham) at 370
for 1 h in final volume of 200 ul containing 50 mM
Tris-HC1 (pH 7.4) and 0.5 U/ml adenosine deaminase.
Incubation was terminated by filtration on glass fibre
filter (Whatman GF/B) under suction. The filter was
washed four times with 3 ml aliquots of ice-cold buffer
B. Radioactivity retained on the f i l ter was de term i ned
by liquid scintillation spectrometry. Non-specific
binding was defined as binding in the presence 100 um
2-chloroadenosine. Specific binding was calculated by
subtracting non-specific binding-from total binding.
2.10.4) Beta-adrenergic receptor binding
Binding assay was performed as described
previously (Bylund and Snyder, 1976 Williams et al,
1976) with some modifications. Assay was initiated by
adding 1 40 u l ad i pocyte or cerebral cortex membrane in
duplicate to 0.3-8OnM 3H-dihydroalprenolol (3H-DHA,
Amersham) at 370 for 30 min in a final volume 200 ul
containing 50 mM Tris-HC1 (pH 7.4). Incubation was
terminated as described in section 2.10.3. Non-specific
binding was defined as binding in the presence of
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100 um propranolol (adipocyte membrane) or 1 mm
isoproterenol (cerebral cortex membrane). Specific
binding was calculated by subtracting non-specific
binding from total binding.
2.10.5) Binding data analysis- Scatchard plot
Radioligand binding to a single eoeulation of non_
interacting site usually follows kinetics similar to
those of classic enzyme-substrate interaction and obeys
the Law of Mass Action. For a reversible ligand-
receptor interaction:
(R)= concentration of unoccupied receptor sites
(L)= concentration of free ligand




Since only a finite number of specific receptor sites
exist.per unit tissue, the ligand-receptor interaction
is saturable. The maximum number of specific receptor









let (RL)= bound ligand= B
(L)= free ligand= F
then
(2.11)
According to the Scatchard equation (2.11), if one
plots B/F vs B, a striaght line can be obtained which
allows the determination of both the dissociation
constant (KD= -1/slope) and the number of binding
sites (Bmax= X-axis intercept).
2.11) Protein Determination
Protein was determined as described by Lowry et al
(1951) with bovine serum albumin (Fraction 5, 98-99%
purity, Sigma) as the protein standard. A typical




























Fig. 2.6: A typical calibration curve for protein determination
using bovine serum albumin (BSA) as standard. Values
presented are the mean of duplicated determinations
from one typical experiment. The straight line was
determined by linear regression analysis. Each
experiment has an individual calibration curve
performed in parallel.
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2.12) Measurement of Adenoeine Dgaminaee Activity
Adenosine deaminase catalyzed the deamination of
adenosine to inosine:
kdenosine+ H2O inosine+ NH3
The activity of adenosine deaminase can be determined
by measuring the rate of disappearance of adenosine
(Agarwal and Parks, 1978). The level of adenosine can
be monitored by measuring its absorbance at 265 nm.
2.12.1) Unit definition
One unit of adenosine deaminase is defined as the
amount of enzyme that catalyzed the deamination of
1 umole of adenosine at pH 7.5 per min at 250.
2.12.2) Preparation of glycerol free adenosine
deaminase
Glycerol free adenosine deaminase (from calf
intestinal, in 50% glycerol-10 mM potassium
phosphate, Sigma) was prepared by dialysing against KRB
for 24 h with three changes of I litre of buffer before
used in lipolytic assay.
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2,12.3) Assay protocol
a) Adenosine solution was prepared freshly in KRB
(section 2.8.1) at the following concentrations:
100, 50, 10, and 5 uM.
b) An aliquot (5 ul) of a properly diluted dialysed
adenosine deaminase was added to a sample cuvette
containing I ml of 5 uM adenosine solution. The
reaction mixture was mixed by inverting the cuvette
with its top on for 3-4 times.
c) By using 5 uM adenosine solution as the reference
blank, The rate of adenosine disappearance was
recorded by monitoring the decrease in absorbance
at 265 nm (slit width I nm) with a pen recorder.
d) Step (b) and (c) were repeated for 10, 50, and







V= enzyme activity (umole adenosine/min)
1= light path= 1 cm
e= molar extinction coefficient of adenosine= 8.1
c= concentration of adenosine
A= absorbance at 265 nm
t= time interval (min)
The initial velocities of the enzyme reaction at
different adenosine concentrations were calculated
according to equation 2.12. A double reciprocal plot
was obtained by plotting 1/V vs 1/C, and the maximal
velocity of adenosine deaminase (Vmax) was determined
as the Y-axis intercept from the double reciprocal
plot. A typical double-reciprocal plot from one
experiment is shown in Fig. 2.7.
2.13) Statistical methods
Comparisons of data were performed using the
following standard statistical methods: correlation






















Fig. 2.7 A double reciprocal plot for adenosine deaminase. Data
presented were that of one typical experiment. The





In preliminary dose-response (0.05%, 0.1% and
0.2%) and time course (3 weeks, 6 weeks, and 9 weeks)
experiments, significant increase in the anti-lipolytic
potency of 2-chloroadenos ine was observed after 6 weeks
0.2% caffeine treatment (Section 3.3). Therefore, this
paradigm was adopted for in-depth evaluation.
3.12 Horobological Aspects of Chronic Caffeine
Treatment
3.1.1) Body weight
After 6 weeks of caffeine (0.2%) treatment, the
body weights of rats were decreased by about 6% when
compared with the controls (Table 3.1). Furthermore,
the caffeine-treated rats displayed a narrower body
weight distribution than the controls (Fig. 3.1).
3.1.2) Epididymal fat pad weight
There was a linear correlation between the body
weight and the epididymal fat pad weight (Fig. 3.1
A,B). However, when compared with the body weight, a
larger decrease in the epididymal fat pad weight (30%
against control) was observed among the caffeine-
treated rats (Table 3.1). As a consequence, an 18%
decrease in the weight proportion of epididymal fat pad
to body weight was obtained in the caffeine-treated






















scatterplot of body wegt vs epididymai at pad
weight of A control and B 0.2% caffeine- treated 6
weeks rats , The correlas on coefficients r were
determiner by linear regression analysis
TADI tr f 1
Effect of chronic caffeine treatment fin rat body flyqht













Values presented are the mean± S.D. of 68 rats Weight proportion are
the ratio of epididymal fat pad weight to body weight P0.0005 with
Students' t-test.
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weight, the caffeine-treated rats also displayed a
narrower ep id idymal fat pad weight distribution than
the controls (Fig. 3.1 A,B)
3.1.3) Mean cell size of adipocytes
After chronic caffeine treatment, there was no
apparent difference in the morphology of adipocytes
(Fig 3.2 A,B), but the cell diameter and cell volume of
adipocytes from 0.2% caffeine-treated rats were about
10% and 30% respectively smaller than that of the
controls (Table 3.2).
3.1.4) Mean cell weight of adipocytes
There was no statistically significant difference
in the mean cell weight of adipocytes between the
control and the caffeine-treated rats (Table 3.2).
3.1.5) Triglyceride content of adipocytes
No statistically significant difference in the
triglyceride content was found between the control and
the caffeine-treated (0.2%) rats expressed either in
term of per mg cell weight or per 105 cell number
(Table-3.3)
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Fig. 3.2: Photomicrographs of free fat cells of (A) control and
(B) 0.2% caffeine-treated (6 weeks) rats. The
adipocytes were obtained from collagenase-treated rat
epididymal adipose tissue.
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339,87
Values presented are the mean f S.D. of 4 rats. No statistica
significant difference P0.05 when compare with controls usin
Students' t-test.
Effect of chronic caffeine treatment on triqlyceride
content of adiocytes
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Values presented are the mean+ S.D. of tour rats. There is no
significant difference between control and caffeine treated rats when
tested by Students' t-test.
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3.2) Some Characteristics of Adipocytes Related to
3.2.1) Dependence of glycerol release on cell
concentration
I n the presence of either adenosine deam i nase
(1 U/ml) or isoproterenol (300 nM), there was a
positive linear correlation between the amount of
glycerol released and cell concentration. This was
true whether the cell concentration was expressed in
terms of cell number or cell weight (Fig. 3.3 and Fig.
3.4) Since the amount of glycerol released correlated
better with cell weight and the determination of cell
weight was more objective, lipolytic rates were
expressed as glycerol release per g cell weight per
unit time.
3.2.2) Characteristics of the adenosine receptors on
adipocytes
In initial experiments, it was observed that the
methylxanthines including caffeine and DPX can
stimulate the release of glycerol from adipocytes
(Figure. 3.5). This suggested that adenosine may
normally exert an inhibitory effect on lipolysis.
Indeed, lowering endogenous adenosine by adenosine
deaminase (1 U/ml) enhanced the lipolytic potency of
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Fig. 3.3: Scatterplot of (A) ce;; mi,ner. pr (B) cell weight vs
glycerol release stimulated by lowering endogenous
adenosine with 1 Uml adenosine deaminase. The
corre1 atrion coe-fF icients (r) were determined by
1inear regression analysiSt
Fig. 3.4: Scatterplot of (A) cell number, or (B) cell weight vs
glycerol release stimulated by 300 nM isoproterenol.
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Fig. 3.5: Stimulation of lipolysis by DPX (AA) and caffeine
(• O) in the presence (closed symbols) and absence
(opened symbols) of 1 Uml adenosine deaminase. Data
showed are that of a typical experiment. Similar
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Fig. 3.6: Dose dependence of adenosine deaminase in the
stimulation of lipolysis. Data showed are that of a
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Fig. 3.7: Effect of 2-chloroadenosine on glycerol release of
basal (A), or stimulated by 1 Uml adenosine
deaminase (O) 10 nM isoproterenol+ 1 Uml adenosine
deaminase (A) 1 uM isoproterenol+ 1 Uml adenosine
deaminase(). Data showed are that of a typical
experiment. Similar results were obtained in two
separate experiments.
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lipolysis in adipocytes can be induced by adenosine
deaminase in a dose-dependent manner, and it reached a
plateau at about 30 U/ml of the enzyme (Fig. 3.6). This
adenosine deaminase stimulated 1ipolysis can be
inhibited completely by 2-chloroadenosine, an adenosine
analogue which resisted the action of adenosine
deaminase (Fig. 3.7 and Fig. 3.13).
To examine the pharmacololgical characteristics of
the adenosine receptors responsible for inhibiting
lipolysis in adipocytes, the effect of several
metabolically stable analogues of adenosine on
isoproterenol (10 nM) stimulated lipolysis were
examined. These drugs inhibited the isoproterenol
stimulated lipolysis in a dose-dependent manner, with
L-PIA being most potent, followed by 2-chloroadenosine
and D-PIA (Fig. 3.8). The high stereo-selectivity for
L-PIA vs D-PIA (approximate 100 fold), conformed with
the pattern suggested for an Al adenosine receptors
mediated response.
3.2.3) Characteristics of the adrenergic receptors on
adipocytes
Norepinephrine (NE) is well-known as a lipolytic
agent. It was, however, ten fold less potent in
promoting the release of glycerol from adipocytes than
isoproterenol (Fig. 3.9). Isoproterenol is a selective


























-LOG CONCENTRATION OF DRUGS, M
Fig. 3.8: Inhibition of 10 nM isoproterenol stimulated iipolysis
in the presence 1 Uml adenosine deaminase by L-PIA
(A) 2-chl oroadenos i ne() and D-PIA CO»
LOG CONCENTRATION OF DRUGS, M
Fig. 3.9: Dose dependence of isoproterenol
norepinephrine in the stimulation of lipolysis
and
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3.2.4) Effect of triglyoeride content on lipolysie
To investigate whether the amount of glycerol
released is affected by the triglyceride content of
adipocytes, rat were treated with isoproterenol to
stimulate lipolysis in vivo. After treatment with
isoproterenol for 6 days (0.2 mg/kg body weight), cell
triglyceride content of adipocytes were increased by
about 2.5 fold (Table 3.4). These adipocytes with
higher triglyceride content gave a higher basal as well
as adenosine deaminase induced glycerol release when
compared with the controls (Fig. 3.12). However, there
was no statistically significant difference in the
anti-lipolytic potency of 2-chloroadenosine between the
controls and the isoproterenol-treated group
(Table 3.5).
It should be noted that under the present assay
conditions, the stimulated glycerol release from
adipocytes was linear up to 90 min when induced with 3
U/ml adenosine deaminase (Fig. 3.13). It is also linear
up to 75 min when stimulated with luM isoproterenol in
the presence of lU/ml adenosine deaminase (Fig. 3.14).
Thus, to avoid any interference as a result of
depletion of triglyceride content in adipocytes, the
rate of lipolysis was measured over a period of 30 min
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Fig. 3.10: Dose dependence of propranolol in the inhibition of
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Fia 3.11: Dose dependence of isoproterenol in the stimulation of
lipolysis in control
1 FT m 1 1 i no
i no
adenosine deaminase+ 1 uM 2—chloroadenosine
Data showed are that of a typical experiment. Similar
results were obtained in three separate experiment.
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3.2.4) Effect of triglyceride content on lipolysis
To investigate whether the amount of glycerol
released is affected by the triglyceride content of
adipocytes, rat were treated with isoproterenol to
stimulate lipolysis in vivo. After treatment with
isoproterenol for 6 days (0.2 mg/kg body weight), cell
triglyceride content of adipocytes were increased by
about 2.5 fold (Table 3.4). These adipocytes with
higher triglyceride content gave a higher basal as well
as adenosine deaminase induced glycerol release when
compared with the controls (Fig. 3.12). However, there
was no statistically significant difference in the
ant i-l ipolyt is potency of 2-chloroadenos ine between the
controls and the isoproterenol -treated group
(Table 3.5).
It should be noted that under the present assay
conditions, the stimulated glycerol release from
adipocytes was linear up to 90 min when induced with 3
U/ml adenosine deaminase (Fig. 3.13). It is also linear
up to 75 min when stimulated with luM iso.proterenol in
the presence of lU/ml adenosine deaminase (Fig. 3.14).
Thus, to avoid andy interference as a result of
depletion of triglyceride content in adipocytes, the
rate of lipolysis was measured over a period of 30 min
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Fig. 3.12: Dose dependence of 2-chloroadenosine in the inhibition
of lipolvsis stimulated by 1 (Jml adenosine deaminase
in contro! and isoproterenol-treated (0.2 mcrkc
bodv weiaht12 h for 6 days) rsts. Data showed
are mean+ S.E.M. of 3 rats.
IABLE
gf f eqt; of i soproterenol treatment on triglyceride
content of ad i oocytes
TRIGLYCERIDE CONTENT
RAT





(0.2 mgkg, s.c., 6 days)
Values presented ane the mean+ S.D. of 3 rats.• P0.05, P0.005
with Students t-test.
TABLE 3.5
Effect o-f i soprotereno 1 treatment on the i nh i b i tory potency




(0.2 mgkg, s.c., 6 days)
1.63+0.49
ICoo is the concentration o-f 2-ch 1 oroadenasine required to inhibite 50%
lipolysis stimulated by 1 Uml adenosine deaminase. Values presented
are the mean+ S.D. of 3 rats. There is no significant difference















































Fig. 3.13: Time dependence of glycerol release from and cAMP
accumulation in adipocytes. Glycerol release was
measured in control 0.5 Uml
1 riml
3 Uml adenosine deaminase;
anrl Q flml arlannc i no
deaminase+ 1 uM 9-fh 1 nrnaHfnr».c; i nf
rM P
accumu1 ation was determined in the presence of















Fig. 3.14: Time dependence of glycerol release stimulated by 1 uM
isoproterenol in the presence of 1 Uml adenosine
deaminase. Data showed are that of a typical
experiment. Similar results were obtained in two
separate experiments.
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3.3) Effect of Chroolc caffeine Treatment on Lipolysis
3.3.1) Dose dependence of chronic caffeine treatment
To test the dose effect of caffeine treatment,
rats were given 0.05%, 0.1%, or 0.2% caffeine solution
for 6 weeks. When compared with controls, rats
treated with 0.05% caffeine demonstrated a higher basal
release of glycerol (Fig. 3.15). However, no
observable difference in the basal release of glycerol
was found in rats treated with either 0.1% or 0.2%
caffeine (Fig. 3.16 and Fig. 3.17). There was also no
significant difference in the rate of lipolysis
stimulated by 1 U/ml adenosine deaminase at all three
doses tested (Fig. 3.15, Fig. 3.16 and Fig. 3.17). In
contrast, the anti-lipolytic potency of 2-chloro-
adenosine increased 2.5 fold in 0.2% caffeine-treated
rats, although there was little or no change in rats
treated with either 0.05% or 0.1% caffeine (Table 3.6).
3.3.2) Time dependence of 0.2% caffeine treatment
To evaluate the effect of time course of caffeine
treatment, rats were treated with 0.2% caffeine
solution for 3, 6 and 9 weeks. There was no significant
difference in the basal release of glycerol throughout
these periods. However, when the rate of 1ipolysis
stimulated by 1 U/ml adenosine deaminase was compared,








-LOG CONCENTRATION OF 2-CHLOROADENOSINE. M
Fig. 3.15: 2-chloroadenosine inhibition of lipolysis stimulated
by 1 Uml adenosine deaminase in control
weeks 0.05% caffeine-treated V n 4 n 4 a p.















-LOG CONCENTRATION OF 2-CHLOROADENOSINE. M
Fin 16 2-ch1oroadenosine inhibition of lipolysis stimulated
by 1 U ml adenosine deaminase in control
weeks 0.1% caffeine-treated
i n=»+-a chnupH
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-LOG CONCENTRATION OF 2-CHL0R0ADENOSINE, M
Fig. 3.17: 2-ch1oroadenosine inhibition of lipolysis stimulated
by 1 Uml adenosine deaminase in control and 6
weeks 0.2% caffeine-treated rats. Data showed
are the mean+ S.E.M. of 8 rats.
TABLF 7
— —-~a- treatment J.6 weeks) on ihe inhibltoj
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ICoo is the concentration o-f 2-chloroadenosine required to inhibit 50
lipolysis stimulated by 1 Uml adenosine deaminase. Caffeine wa
adminstrated to rats by replacing the drinking water with caffein
solution -for 6 weeks. Values presented are the mean+ S.D. o-f (n
rats. No statistical significant difference. P0.002 wit
Students' t-test.
TAT3I ET ~X
Effect of time course, of 0.2% caffeine treatment; on the inhibitory













vu mnrpntration of 2-chloroadenosine required to inhibit 50%
IC°°, 15 stimulated by 1 U»l adenosine deaminase. Caffeine Has
lipolysis imula by replacing the drinking Hater with 0.2% caffeine
administrated t .t dlcated. Values presented are the
solution for No statistical significant difference.
....~, ~Z v v v pn .002 with Students' t-test.
95
lower rate of lipolysis than that of rats treated for 3
and 6 weeks (Fig.3.17, Fig. 3.18 and Fig. 3.19).
Furthermore, significant difference in the anti-
1ipolytic potency of 2-chloroadenosine was observed
after 6 and 9 weeks of 0.2% caffeine treatment (Table
3.7). Therefore, 6 weeks of 0.2% caffeine treatment
was chosen as a model for further study.
3.3.3) Effect of chronic caffeine treatment (0.2%. 6
weeks) on isoproterenol stimulated lipolysis
Although there was no significant difference in
the rate of lipol ys is stimulated by 30 U/ml adenosine
deaminase (Table 3.8), there was about a 40% decrease
in the rate of lipolysis stimulated by luM
isoproterenol in caffeine-treated rats (Fig. 3.20). A
significant decrease in the lipolytic potency of
isoproterenol was also noticeable after chronic caffeine
treatment (Table 3.9).
Fig , 3.18. 2 - chlordenosing inibition of lipolysis stimulatad
by 1 u/m 1 adenosine deaminase in contro and 3
weeks 0.2% caffeine- treated (0) rats
Data showed






-LOG CONCENTRATION OF 2-CHLOROADENOSINE, f
Fig. 3.19: 2-chloroadenosine inhibition of lipolysis stimulatec
by 1 Uml adenosine deaminase in control() and S
weeks 0.2% caffeine-treated (O) rats. Data showed







































-LOG CONCENTRATION OF ISOPROTERENOL, M
Fig. 3.20: Dose dependent stimulation of lipolvsis by
isoproterenol in control And ft wppks
caf fe ine-treated rats. Data showed are the
mean+ S.E.M. of 6 (control) and 7 (caffeine-treated)
rats. P0.05 P0.06 with Students' t-test.
t of chronic caffeine treatment (0.2%. 6 weeks) on UpgfyB




Ca-f-feine was administrated to rats by replacing the drinking water wit
0.2% ca-fteine solution -for 6 weeks. Values presented are tf-
mean f S.D. of 4 rats. There is no significant difference betwee
control and caffeine-treated rats when tested by Students t-test.
TADI C T
Effect of chronic caf f eine treatment (0.2%. 6 weeks) on the




EC00 is the concentration of isoproterenol required to obtain halt
maximum stimulated lipolysis. Caffeine was administrated to rats by
replacing the drinking water with 0.2. caffeine solution for 6 weeks.
Values presented are the mean+ S.D. of (n) rats. PC0.O6 with
Stidemnts't-tesst.
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3.4) Lipolysis and cAMP Accumulation
3.4.1) Accumulation of cAMP in intact adipocytes
In agreement with previously reports (Schimmel
et al, 1981 Bojanic and Nahorski, 1984), isoproterenol
stimulated cAMP accumulation in adipocytes in a dose
dependent manner (Fig. 3.21). The accumulation of cAMP
in adipocytes stimulated by 100 uM isoproterenol in the
presence of I U/ml adenosine de am i nase, can be
inhibited by 2-chloroadenosine in a dose dependent
manner (Fig. 3.24).
3.4.2) Relationship between cAMP level and lipolysis
Although there is evidence suggesting that the
intracellular cAMP level may modulate lipase activity,
which in turn regulates the rate of lipolysis, the
relationship between cAMP level and lipolysis is not a
straight forward one. For instance, while isoproterenol
stimulated cAMP accumulation in dose-dependent manner
up to 100 uM, this was not so for lipolysis which
decreased when the concentration of isoproterenol was
greater than 1 uM (Fig. 3.21). Moreover, in the
presence of 100 uM isoproterenol, cAMP level reached
maximum level after 6-8 min (Fig. 3.22) and then
gradually returned to control level by 24 min but
lipolysis was maintained at a steady rate for at least
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Fig. 3.22: Time dependent accumulation, of cAMP in intact fat cell
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Fig. 3.23: Time dependent accumulation of cAMP( and glycerol
release CO stimulated by 100 uM isoproterenol in
intact adipocytes.
The presence of I Uml adenosine deaminase can
stimulate lipolysis (Fig. 3.7), however, no
accumulation of cAMP was detected under this condition
for up to 90 min (Fig. 3.13). Furthermore, in the
presence of 1 Uml adenosine deaminase, 2-chloro-
adenosine did not inhibit lipolysis stimulated by 1 uM
isoproterenol (Fig. 3.7), but cAMP accumulation
stimulated by 100 uM isoproterenol was inhibited by 2-
chloroadenosine in a dose-dependent manner (Fig. 3.24).
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3.5) Effect of Chronic Caffeine Treataent (0.2%.6
weeks) on cAMP Accumulation in Intact Adipocytes
3.5.1) Effect of 2-chloroadenosine on isoproterenol
stimulated cAMP accumulation
Although there was an increase in the anti-
1 ipol yt is potency of 2-chloroadenosine after chronic
caffeine treatment (Table 3.7), no significant
difference in the inhibitory potency of 2-chloro-
adenosine was observed for-its inhibitory effect on
100 uM isoproterenol-stimulated cAMP accumulation in
the presence of i U/ml adenosine deaminase (Fig. 3.24
and Table 3.10). There was also no difference in the
basal level of cAMP in adipocytes prepared from the
control and the caffeine-treated rats.
3.5.2) Effect on cAMP accumulation stimulated by
isoproterenol
In agreement with the decrease of l-ipolytic
response to isoproterenol stimulation, chronic caffeine
treatment also reduced the isoproterenol-stimulated
cAMP accumulation in intact adipocytes (Fig. 3.25). In
addition, in the presence of 1 U/ml adenosine
deaminase, cAMP accumulation stimulated by 100 uM
isoproterenol decreased about 50% when compared with
that of the controls (Fig. 3.24).
8 7 6
-LOG CONCENTRATION OF 2-CHLOROADENOSINE. M
Fig. 3.24: Inhibition of cAMP accumulation stimulated by 100 uM
isoproterenol in the presence 1 Uml adenosine
deaminase in control and 6 weeks 0.2% caffeine-
treated rats. Adipocytes obtained from 4 rats
were pooled for the assays. Data showed are the
mean+ S.E.M. of two separate experiments.
TABLBE 3.10
Effect of chronic caffelne treatment (0.2%« 6 weeks) an the inhibitorv






ICao is the concentration of 2-chloroadenosine required to inhibit 50%
of tne cAMP accumulation stimulated by 100 uM isoproterenol in the
presence of 1 Uml adenosine deaminase. Adipocytes isolated from 4 rats
were pooled for assay in duplicate. Values presented are the
mean+ S.D. of two separete caffeine treatments. There is no
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Fiq. 3.25: Dose dependent stimulation of cAHP accumulation bv
isoproterenol in control
caffeine-treated A I «r 4 a 4• m a£ «a ma
4 rats were pooled for the assays. Data showed are
that of a typical experiment. Similar results were
obtained in two separate experiments.
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3.6.1) Adeonslne receptors
The binding of 3H-PIA to rat cerebral cortex and
adipocyte membranes was monophasic and saturable (Fig.
26 and Fig. 27), with a Kq value of 1.45 and 1.54 nH
respectively. However, the density of 3H-PIA binding
sites in adipocytes membranes was about 2 fold higher
than that of the cerebral cortex (Table 3.11).
After chronic caffeine treatment, there was no
significant change in the binding affinity for 3H-PIA
in both cerebral cortex and adipocyte membranes (Table
3.11 and Fig. 3.27). In contrast, the maximum number
of 3H-PIA binding sites (Bmax) in adipocyte membranes
was increased by about 45% (Table 3.If). Although a
consistent 10-20% increase in the 3H-PIA binding sites
was also observed in cerebral cortical membranes, it
did not reach statistical significance(Fig. 3.26).
3.6.2) Beta-adrenergic receptors
The binding of 3H-DHA to cerebral cortex membrane
was monophasic and saturable (Fig. 3.28), with a KD
value of 2 nM and a Bmax value of 227 fmolemg protein





















































Fig. 3.26: (A) Saturation curve of 3H-PIA binding to rat fat cell
membranes of control(• O) and 6 weeks 0.2% caffeine-
treated C AA rats. Adipocytes obtained from 4 rats
of each group were pooled for the assays. Non¬
specific binding (OA) was defined as the binding in
the presence of 100 uM 2-chloroadenosine. Specific
binding (A) was obtained by substraction of non¬
specific binding from total binding. CB) Scatchard
plot of the same data is showed. Data showed are that
of a typical experiment. Similar results were obtained
in three separate experiments.
ACONCENTRATION OF
BOUNE fnolmq prottln
Fig. 3.27: CA) Saturation curve of 3H-PIA binding to rat cerebral
cortex membranes of control 0 and 6 weeks 0.2%
caffeine-treated (A A) rats. Tissue from 4 rats of
each group were pooled for the assays. Non-specific
binding CO A) was defined as the binding in the
presence of 100 uM 2-chloroadenosine. Specific
binding(• A) was obtained by substraction of non¬
specific binding from total binding. (B) Scatchard
plot of the same data is showed. Data showed are that
of a typical experiment. Similar results were obtained
in 4 separate experiments.
Ill
IABLE 3.11
Effect of chronic caffeine treatment (0.2§ weeks) on 3H-PIA binding











CONTROL 1.45+0.38 (4) 630+97 (4) 1.54+0.36 (3) 1450+107 (3)
CAFFEINE- 1.49+0.45 (4) 750+116 (4)
TREATED
1.53+0.24 (3) 2076+65 (3)
Caffeine was administrated to rats by replacing drinking water with 0.2X
caffeine solution for 6 weeks. Tissues froa 4 rats were pooled for the binding
assays. Values presented are the aean+ S.D. of (n) separate caffeine-


























































Fig. 3.28: CA) Saturation curve of H-DHA binding to rat cerebral
cortex membranes. Tissue from 4 rats were pooled for
the assay. Non-specific binding (0 was defined as
the binding in the presence of 1 mM isoproterenol.
Specific binding(•) was obtained by substraction of
non-specific binding from total binding. (B)
Scatchard plot of the same data is showed. Data
showed are that of a typical experiment. Similari
results were obtained in 5 separate experiments.
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adipocyte membrane was sigmoidal, suggestive of a
cooperative process (Fig. 3.29).
After chronic caffeine treatment, the binding of
3H-DHA to adipocyte membranes became monophasic,
accompanied with a decrease in the receptor density
(Fig. 3. 2 9). No significant difference in KD and
Bmax, however, was observed in the binding of 3H-DHA to
cerebral cortex membranes (Table 3.12).
Fig. 3.29:Saturation curve of 3H-DHA binding to rat fat cell
membranes prepared from control() and 6 weeks 0.2
caffeine-treated( o rats. Adipocytes from 4 rats of
each group were pooled for the assays. Non~specific
binding was defined as the binding in the presence of
100 uM propranolol. Data showed are that of a typical
experiment. Similar results were obtained in two
separate experiments.
TABLE 3.12
Effect of chron1c caffe1ne treatment on 3H~DHA binding ifi
rat cerebral cortex membranes
RAT Kn (nM) 5mM (fmolemq protein)
CONTROL 2.1l+O.65 226.83+99.12
CAFFEINE-TREATED 2.08+0.72 208.63+30.86
Caffeine was administrated by replacing the drinking water with 0.2%
caffeine solution for 6 weeks. Tissues from four rats were pooled for
the binding assays. Non-specific binding was defined as the binding in
the presence of 1 mM isoproterenol. Values presented are the
mean+. S.D. of 3 separate caffeine treatments. There is no statistical
significant difference between control and caffeine-treated groups when




4.1) The moreholbgical aseect of chronic caffeine
consumption.
Similar to a previous report (Johansson, 1978),
rats were found to have a lower body weight when
compared with age matched controls after chronic
caffeine consumption (Table 3.1). In addition, the
present study revealed a smaller epididymal fat pad
weight as well as a lower adipocytes size (Table 3.1
and Table 3.2). These results tempt to suggest there
may be a retardation of growth afte.r chronic caffeine
treatment, Since caffeine can block the cellular re-
uptake of adenosine at high concentration (Marangos et
al, 1982), therefore, chronic caffeine treatment may
decrease the re-uptake and hence the re-utilization of
adenosine. Thus more energy is required for the de novo
synthesis of adenosine during caffeine treatment and
this may slow down the normal growth rate.
Usually, adipose tissue contains 60-85% of lipid,
of which 90-95% are tr igl ycer ides (Jeanrenaud, 1965). A
decrease in the a pididymal fat pad weight may be the
result of a decrease in the adipocyte triglyceride
content or a decrease in the adipocyte number. In
spite of a smaller adipocytes size, there was no change
in the mean cell weight and cell triglyceride content
tes after the chronic caffeine treatment
in adipocy
(Table 3.2 and Table 3.3), Thus, the lower epididymal
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fat pad weight was most likely due to a decrease in
adipocyte number.
4.2)- -Up regulation of adenosine receetors after chronic
caffeine treatment
Similar to a previous report (Fredholm et al,
1984), the present study demonstrated that adenosine
exerted its. anti-1ipolytic action via the Al adenosine
receptors in rat adipocytes. However, a small lipolytic
activity of 2-chloroadenosine and adenosine can be
obtained at high concentration of these compounds. This
may suggest the existence of other adenosine receptors
subtypes in ad ipocytes. More studies are, therefore,
required to characterise the l ipolyti-c activity of
adenosine and its analogues.
In the present study, it was found that the anti-
1 ipolyt is potency of 2-chloroadenos ine increased 2.5
fold after chronic 0.2% caffeine treatment (Table 3.6
and Table 3.7): This is in agreement with the
observation that the hypotensive action of adenosine is
increased after chronic caffeine consumption (Borstek
et ai, 1983). Furthermore, the present study also
confirmed Fredholm's observation (1982-) that no change
in the inhibition of lipolysis by 2-chloroadenosine was
obtained after 0.1% caffeine treatment for 1, weeks.
Adaptive changes in adenosine receptors can, however,
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be obtained by increasing the caffeine dosage and
prolonging the duration of treatment (Table 3.6 and
Table 3.7).
Although a consistent 10-20% increase in brain
adenosine receptors was observed in the 0.2% caffeine-
treated rats, it was not significantly different from
the control (Table 3.10). In contrast, significant
up-regulation of brain adenosine receptors has been
reported previously (Fredholm, 1982 Murray, 1982
Boulenger et al, 1983 Wu and Coffin, 1984 Green and
Stiles, 1986).. This discrepancy may be the result of
,storage of the cerebral cortex at -20° for about 48 h
before assayed for receptors in the present study,
while receptor assays were performed on fresh tissue in
the previous reports.
In contrast to the cerebral cortex, an increase in
the number of adenosine receptors with no change in
affinity for 3H-PIA was observed in adipocytes
membranes after chronic 0.2% caffeine treatment (Table
3.10). According to the 'Law of Mass Action', at a
fixed drug concentration, the number of receptors being
occupied is determined by the total number of receptors
present as well as by its affinity for the drug. Since
a biological response is' proportional to the number of
receptors being occupied (Stephenson, 1956).. an
increase in the anti-lipolytic potency of 2-chloro-
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adenosine upon chronic caffeine treatment may be
attributed to an increase in receptor occupancy as a
result of increase in adenosine receptor number in
adipocytes.
Adenosine deaminase can stimulate lipolysis
presumably by removing endogenous adenosine which is
released from adipocytes (Fig. 3.7). In the present
study, when lipolysis was stimulated with 30 U/ml
adenosine deaminase, there was no difference in the
lipolytis rate between the control and caffeine-
treated rats (Table 3.8), suggesting that there was no
change in the li-polytic pathway. This finding further
supports the notion that the increase in the anti-
lipolytis potency of 2-chl oroadenosine may be due to an
increase of adenosine receptor number in the
adipocytes. Although an increase in the coupling
efficiency of adenosine receptor with its effector
machinery cannot be ruled out in the present study.
In spite of an increase in the potency of 2-
chloroadenosine to inhibit adenosine deaminase
stimulated lipolysis after chronic caffeine treatment,
there was no change in the inhibitory potency of 2-
chloroadenosine on cAMP accumulation stimulated by
isoproterenol (Fig. 3.24 and Table 3.10). This
discrepancy may suggest that the anti-lipolytic action
of 2-chloroadenosine and the inhibition of cAMP
accumulation by 2-chloroadenosine are two separate
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events with no causal relationship. This notion was
further supported by the absence of cAMP accumulation
in the intact adipocytes when lipolysis was stimulated
by the addition of adenosine deaminase (Fig. 3.13).
4_3) Down regulation of beta_adreneroic receetors after
chronic caffeine treatment
In the present study, the adrenergic receptors in
adipocytes was characterized to be a beta-adrenergic
type. Previous reports suggested the beta-adrenergic
receptors of adipocytes should be the beta -adrenergic
receptors (Fain, 1973 Meisner and Carter, 1977
Garcia-sAinz and Fain,1980). However, recent evidence
suggested the beta-adrenoceptor of rat adipocytes was
neither a be tat nor a beta 2 type o but rather a hybrid
of beta1 and beta2-adrenoceptors (Bojanic and Nahorski,
1984 Vente et a], 1980).
The increase of anti-lipolytic *potency of 2-
chloroadenosine after chronic caffeine treatment, there
was accompanied by a decrease in the lipolytic response
to isoproterenol (Fig. 3.25). A corresponding decrease
in 3H-DHA binding sites on adipocytes membranes
(Fig. 3.29) was also observed together with a parallel
decrease in the cAMP accumulation stimulated by
isoproterenol either in the presence or absence of
adenosine deaminase (Fig. 3.24 and Fig. 3.25). Thus,
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upon chronic caffeine treatment, the adipocytes are
less responsive to the beta-adrenergic stimulation for
lipid mobilization.
Previously, it has been demonstrated that chronic
activation of beta-adrenergic receptors may lead to a
down regulation of these receptors as reflected by a
decrease in receptor numbers (Chuang and Costa, 1979
Reisine, 1981). The down-regulation of 3H-DHA binding
sites on adipocytes membrane observed in the present
study suggested that the adrenerg.ic system of adipose
tissue was overactivated during chronic caffeine
treatment.
Both brown and white adipose tissue are innervated
by adrenergic- nerve fibers (Wirsen, 1965 Meisner and
Carter, 1977). As reviewed by Paton (1979), adrenergic
neurotransmission can be inhibited presynaptically by
adenosine (Fig. 4. 1). Since caffeine is an adenosine
receptor antagonist, it is conceivable that the
presynaptic inhibition of adrenergic transmission by
adenosine can* be decreased by chronic caffeine
treatment, resulting in an increased release of
norepinephrine when stimulated. Thus the adrenergic
system of adipose tissue may be indirectly over-
activated during chronic caffeine treatment.
It was found in the present study that, in the














Roles of adenosine in the regulation of
Fig. 4.1:
norepinephrine release from adrenergic
nerve endings and lipolysis.
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change in the lipolytic dose response curve of
isoproterenol. It was, however, shifted towards the
left when 1 U/ml adenosine deaminase was added
(Fig. 3.11). This result suggests that under normal
condition, the endogenous adenosine keeps the lipolytic
response of adipocytes to beta-adrenergic stimulation
in check (Fig. 4.1). Thus, during caffeine treatment,
the presence of an adenosine receptor. antagonist can
partly offset the inhibitory tone of adenosine on
lipolysis. -This may also result in an indirect over-
activation of the beta-adrenergic system. Such 'cross-
talk' between different receptor systme is not uncommon
and has recently been reviewed by Hollenberg (1985).
It has been reported that the norepinephrine
stimulated lipolysis linearly correlated with the
adipocytes cell size (Reardon, 1973 Vernon and Finley,
1985). Therefore, the decrease in mean cell diameter
may be another explanation for the decrease in
1ipolytis response to isopro to re no 1. However, it
should be noted that there was only a 10% decrease in
the cell diameter (Table 3.2), but there was about 40%
decrease in the lipoiytic response (Fig. 3.20).
a corresponding down-regulation of 3H-DHA
Moreover,
binding site was observed (Fig. 3.29). Therefore, the
decrease in mean cell diameter after chronic caffeine
treatment may account for only part of the decrease in
the lipol yt is response to isoproterenol.
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It has been 'reported previously that there was a
down regulation of brain beta-adrenergic receptors
after long-term administration of caffeine or
theophy1line (Goldberg et al, 1982 Fredholm et al,
1984 Green and Stile, 1986). However, no significant
change in the cerebral cortex beta-adrenergic receptors
was observed in the present study (Table 3.11). As the
radioligand used for labelling beta-adrenergic
receptors and the brain' region examined in the present
study were different from those reported previously,
the discrepancy may be related due to the difference of
the tissues as well as the radioligand used.
4.4) General discussion on the chronic caffeine
treatment
A cup of coffee contains 75- 150 mg caffeine
(Fredholm, 1980). For a person with a body weight of
75 kg who consumes 3 cups of coffee each. day, his
caffeine consumption amounts to 3- 6 mg/kg. In the
present study, the effect of chronic ingestion of 60-
280 mg/kg/day of caffeine was examined in rats. As a
matter of fact, rats have a higher metabolic rate.
Indeed, pharmacokinetics studies illustrated that a
2.5 fold higher caffeine dose is required to elicit a
similar pharmacological response in rats when compared
with men (Cardinale, 1980). Furthermore, a relatively
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shorter time period of caffeine treatment is requried
for experimental purpose. Thus the present caffeine
dosage were adopted as an animal model for habitual
caffeine consumption in men.
Long-term heavy caffeine consumption has been
report to induce syndromes including vertigo, headache,
and nervousness (Powers, 1925). Recent evidence
suggest the biological effect of caffeine may be due to
its antagonism of adeno's ine receptors (Fredhol m, 1980
Snyder and Sklar, 1984). Since adenosine is an anti-
lipolytic agent in adipocytes, an increase in lipolysis
in response to lipolytic stimuli is expected during
caffeine treatment. The present finding of a
'heightened' adenosine inhibition together with a
'dampered' adrenergic stimulation in adipocytes after
chronic caffeine treatment suggests that an adaptive
response has been in operation to compensate for the
lipolytic action of caffeine.
It has been reported that long-term caffeine
consumption also induced an up-regulation of brain
benzodiazepine receptors (Boulenger et al, 1983 Wu and*
Coffin, 1984). Therefore, the biological effect of
long-term caffeine consumption in the central nervous
system may involve a more complicate adaptive changes
of receptors in addition to the adenosine and beta-
adrenergic receptors.
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In addition' to chronic caffeine treatment, the
responsiveness of adenosine receptors on adipocytes was
reported to be modulated in some patho-physiological
conditions:
(1) Anti-lipolytic potency of N6-phenyl isopropyl-
adenosine (PIA), a metabolic stable adenosine
analogue of adensine, increases during lactation
in rat (Vernon et al, 1983) and sheep (Vernon
and Finley, 1985).
(2) Anti-lipolytic action of PIA decreases after
starvation (Chohan et al, 1984)
(3) Anti-lipolytic action of PIA increases in
hypothyroidism (Chohan et al, 1984)
The results of these studies suggest that
adenosine is an important physiological regulator of
lipolysis. However, the relative importance of
adenosine and insulin as a physiological anti-lipolytic
agent remains to be investigated.
Although the present study suggests that caffeine
may be effective for slimming purpose, its stimulatory
effect on the central nervous system and cardiovascular
system should not be overlooked (Colton, 1967 Snyder
and Sklar, 1984). In fact, long-term treatment with
caffeine has been reported to cause myocardial fibrosis
and markedly reduced life-span in rats (Johansson,
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1981). Thus, caffeine is not recommended for the
purpose of slimming.
4.5) Lipolysis and cAMP accumulation
Currently, it is widely accepted that lipolytic
hormones stimulate the accumulation of cAMP in
adipocytes. An elevated intracellular cAMP level will
dissociate the regulatory unit from the catalytic unit
of a cAMP dependent kinase, which in turn will activate
the hormone-sensitive lipase by transferring a
phosphate group from ATP to the lipase. However, the
present study and several previous reports indicate
that the relationship between cAMP level and lipolysis
is not a straight forward one. For instance:
(1) Isoproterenol stimulated cAMP accumulation
peaked at 6-8 min and then gradually return to
the pre-stimulated level, whereas lipolysis
continued at a steady rate for at least 30 min
(Fig. 3.23 Schimmel, 1974 Butcher et al,
1968).
(2) Lipolysis stimulated by supramaximal
concentration of isoproterenol was not inhibited
by adenosine or its stable analogues. However,
isoproterenol stimulated cAMP accumulation was
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susceptible to inhibition by 2-chloroadenosine
(Fig. 3.7 and Fig. 3.25 Trost and Stock, 1979).
(3) Adenosine deaminase and methylxanthine can
stimulate lipolysis, however, no noticeable
accumulation of cAMP was detected under these
conditions (Fig. 3.13 Butcher et al, 1968).
(4) After pre-treatment of adipose tissue with an
lipolyt is agent, one can obtain further
stimulation of lipolysis upon a second
application of the lipolytic agent. This second
stimulated response, however, was not
accompanied by cAMP accumulation (Schimmel,
1973).
(5) After two hour incubation of adipocytes with
tritium labeled cAMP or dibutyryl-CAMP, same
amount of radiolabeled cAMP and dibutyryl-CAMP
was found in the adipocyte extract. This result
suggested that both cAMP and dibutyryl-cAMP can.
penetrate into the adipocytes and to the same
extent,, although a higher degradation rate of
cAMP was expected. However, only dibutyryl-cAMP
induced lipolysis in vitro (Okuda et al, 1975)
(6) Local anaesthetics inhibited lipolysis but
stimulated cAMP accumulation in adipocytes
(S iddle and Hales, 1974)
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In addition to the cAMP theory, calcium ion has
recently been implicated in the regulation of lipolysis
(Schimmel, 1973 Siddle and Hales et aI, 1974 Hales et
al, 1974 Goko et al, 1984). However, there was no
observable increase in the turnover rate of
phosphatidylinositol in adipocytes when lipolysis was
stimulated with ACTH and dibutyryl-cAMP (Garcia-SAinz
and Fain, 1980).
It has also been suggested by Okuda and co-workers
(1974) that lipolysis was stimulated by alteration in
the interaction between a lipase and the triglyceride
globule in adipocytes rather than as a result of an
activation of lipase by a cAMP-dependent protein
kinase. Nevertheless, a thorough understanding of the
mechanism underlying hormone induced 1ipolysis will
successful purification and
require the
characterization of the hormone-sensitive lipase as
well as other 1ipolytic enzymes of adipocytes.
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CONCLUSION
After chronic caffeine treatment (0.2%. 6 weeks),
there was a decrease in the body weight, epididymal fat
pad weight, and mean cell diameter of adipocytes when
compared with that of the controls. However, there was
no difference in the tr igl ycer ide content and the mean
cell weight of adipocytes between the control and the
caffeine-treated rats.
Lipolysis induced by adenosine deaminase was not
different between the control and the caffeine-treated
rats. However, an increase in the anti-lipolytic
potency of 2-chloroadenosine, a stable adenosine
analogue, was observed after chronic caffeine
treatment. This was accompanied by an increase in the
number of adenosine receptors in the adipocytes.
On the other hand, a diminished lipolytic
response to isoproterenol, an beta-adrenergic agonist,
was obtained in the caffeine-treated rats.
Furthermore, cAMP accumulation stimulated by
isoProterenol in intact adipocytes was decreased both
in the presence and absence of adenosine deaminase
after the chronic caffeine treatment. In agreement with
the decrease in lipolytic response and cAMP
accumulation to isoproterenol, a decrease in the number
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of beta-adrenergic receptor was also observed in these
adipocytes.
Since caffeine is an adenosine receptor
antagonist, an increase in lipolysis is expected during
caffeine treatment. The present finding of a
'heightened' adenosine inhibition together with a
'dampened' adrenergic stimulation in adipocytes after
chronic caffeine treatment, suggests an adaptive
response. has been in cooperation to compensate for the
lipolytic action of caffeine.
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